Attana

Attana provides the life science community with world-class instruments and services for validating, selecting and optimizing drug candidates. Our track record of 70+ analyzed candidates has so far shown 100% accuracy in determining which candidates will succeed in clinical trials, improving clinical trials success rates and increasing productivity. 

Attana was founded with the vision of in vitro characterization of molecular interactions, mimicking in vivo conditions. We have developed proprietary label free biosensors for biochemical, crude, sera, and cell-based assays. We are also developing the Attana Virus Analytics (AVA) platform, a proprietary in vitro diagnostics (IVD) tool, for e.g. SARS-CoV-2 testing and immunity profiling. 

To learn more about our latest services and products, please visit www.attana.com or contact info@attana.com.